Li J, Fredette J, Dhanikonda N, Jhaveri M, et al. Clinical Outcomes of Metastatic Urothelial Carcinoma Patients Discontinuing Enfortumab Vedotin Due to Toxicity and/or Clinical Response. Clin Genitourin Cancer 2026;24:102631.
PMID: 42618453